The MET Receptor Tyrosine Kinase is a potential novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma

Recurrent/metastatic head and neck cancer remains a devastating disease with insufficient treatment options. We investigated the MET receptor tyrosine kinase as a novel target for the treatment of head and neck squamous cell carcinoma (HNSCC). MET/phosphorylated-MET and HGF expression were analyzed...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Seiwert, Tanguy Y., Jagadeeswaran, Ramasamy, Faoro, Leonardo, Janamanchi, Varalakshmi, Nallasura, Vidya, Dinali, Mohamed El, Yala, Soheil, Kanteti, Rajani, Cohen, Ezra E.W., Lingen, Mark W., Martin, Leslie, Krishnaswamy, Soundararajan, Klein-Szanto, Andres, Christensen, James, Vokes, Everett E., Salgia, Ravi
פורמט: Artigo
שפה:Inglês
יצא לאור: 2009
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2871252/
https://ncbi.nlm.nih.gov/pubmed/19318576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-08-2881
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים